SCHEMBL6310907

SCHEMBL6310907

CCOC(=O)c1cccc2c1[nH]c1c(C#N)c(C)c(-c3ccccc3)c(=O)n12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 13/20 0.49
ALDH1A1 P00352 9/20 0.49
GAA P10253 5/20 0.49
HPGD P15428 5/20 0.49
MAPT P10636 5/20 0.49
GLA P06280 4/20 0.49
KMT2A Q03164 2/20 0.49
STAT6 P42226 1/20 0.49
HIF1A Q16665 1/20 0.49
HTT P42858 3/20 0.46
NPSR1 Q6W5P4 3/20 0.46
RXFP1 Q9HBX9 1/20 0.46
APAF1 O14727 3/20 0.43
ATM Q13315 2/20 0.43
LMNA P02545 1/20 0.43
NOD2 Q9HC29 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6311981 0.76 KDM4E (0.66) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL6312026 0.73 KDM4E (0.55) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL6310096 0.71 SMN1; SMN2 (0.45) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL6312986 0.69 KDM4E (0.56) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL6311187 0.69 KDM4E (0.53) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL6318678 0.69 KDM4E (0.61) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL6312034 0.68 KDM4E (0.55) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL5449941 0.68 KDM4E (0.42) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL9619404 0.68 ALDH1A1 (0.55) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL9236279 0.68 TSHR (0.63) KDM4EALDH1A1GAAHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 KDM4E 3360/4885ALDH1A1 2550/4885GAA 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.